These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28756593)

  • 61. Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma.
    Minniti G; Paolini S; Antonelli M; Gianno F; Tini P; Lanzetta G; Arcella A; De Pietro R; Giraffa M; Capone L; Romano A; Bozzao A; Esposito V
    J Neurooncol; 2023 Sep; 164(2):331-339. PubMed ID: 37665475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.
    Thomas AA; Fisher JL; Hampton TH; Christensen BC; Tsongalis GJ; Rahme GJ; Whipple CA; Steel SE; Davis MC; Gaur AB; Lewis LD; Ernstoff MS; Fadul CE
    Cancer Immunol Immunother; 2017 Mar; 66(3):379-389. PubMed ID: 27942839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety of temozolomide use in adult patients with renal dysfunction.
    Garzio K; McElroy K; Grossman S; Holdhoff M; Ozer B; Yankulina O
    J Neurooncol; 2022 Sep; 159(3):591-596. PubMed ID: 36001203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sustained CD4
    Ellsworth S; Balmanoukian A; Kos F; Nirschl CJ; Nirschl TR; Grossman SA; Luznik L; Drake CG
    Oncoimmunology; 2014 Jan; 3(1):e27357. PubMed ID: 24790790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma.
    Nathan JK; Brezzell AL; Kim MM; Leung D; Wilkinson DA; Hervey-Jumper SL
    J Neurooncol; 2017 Nov; 135(2):325-333. PubMed ID: 28744829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection.
    Touma W; Hoostal S; Peterson RA; Wiernik A; SantaCruz KS; Lou E
    J Clin Neurosci; 2017 Jul; 41():75-77. PubMed ID: 28291643
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.
    Omar AI; Mason WP
    Core Evid; 2010 Jun; 4():93-111. PubMed ID: 20694068
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of astrocytomas.
    Gonzalez J; Gilbert MR
    Curr Opin Neurol; 2005 Dec; 18(6):632-8. PubMed ID: 16280673
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Temozolomide-induced liver damage. A case report.
    Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
    Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
    [TBL] [Abstract][Full Text] [Related]  

  • 70. BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
    Sanchez-Perez L; Choi BD; Reap EA; Sayour EJ; Norberg P; Schmittling RJ; Archer GE; Herndon JE; Mitchell DA; Heimberger AB; Bigner DD; Sampson JH
    Cancer Immunol Immunother; 2013 Jun; 62(6):983-7. PubMed ID: 23591978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma.
    Zheng J; Wang C; Liu F
    World Neurosurg; 2018 Sep; 117():316-320. PubMed ID: 29960094
    [TBL] [Abstract][Full Text] [Related]  

  • 72. First-line therapy with temozolomide induces regression of primary CNS lymphoma.
    Herrlinger U; Küker W; Platten M; Dichgans J; Weller M
    Neurology; 2002 May; 58(10):1573-4. PubMed ID: 12034807
    [No Abstract]   [Full Text] [Related]  

  • 73. Brainstem Glioblastoma Multiforme in a Patient with NF1.
    Fortunato JT; Reys B; Singh P; Pan E
    Anticancer Res; 2018 Aug; 38(8):4897-4900. PubMed ID: 30061266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection.
    Gai XJ; Wei YM; Tao HM; An DZ; Sun JT; Li BS
    Onco Targets Ther; 2016; 9():5117-21. PubMed ID: 27574452
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
    Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients.
    Iversen TZ; Brimnes MK; Nikolajsen K; Andersen RS; Hadrup SR; Andersen MH; Bastholt L; Svane IM
    Oncoimmunology; 2013 Feb; 2(2):e23288. PubMed ID: 23525955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer.
    Dovšak T; Ihan A; Didanovič V; Kansky A; Verdenik M; Hren NI
    BMC Cancer; 2018 Mar; 18(1):235. PubMed ID: 29490633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients.
    Sage EK; Schmid TE; Sedelmayr M; Gehrmann M; Geinitz H; Duma MN; Combs SE; Multhoff G
    Radiother Oncol; 2016 Jan; 118(1):176-80. PubMed ID: 26683801
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer.
    Campian JL; Ye X; Sarai G; Herman J; Grossman SA
    Cancer Invest; 2018; 36(6):356-361. PubMed ID: 30095290
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of Temozolomide in the Treatment of Cancers Involving the Central Nervous System.
    Schreck KC; Grossman SA
    Oncology (Williston Park); 2018 Nov; 32(11):555-60, 569. PubMed ID: 30474103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.